München
13.03.26 | 08:16
0,422 Euro
0,00 % 0,000
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,401 | 0,409 | 14.03. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.02. | Senzime Launches TetraCom Connectivity Platform Enabling Universal Transmission of Anesthesia Data | 241 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / February 19, 2026 / Senzime AB (publ) (STO:SEZI)(OTCQX:SNZZF) today announced the launch of the TetraCom TM hospital connectivity platform. TetraCom is a first of its... ► Artikel lesen | |
| 18.02. | Senzime AB (publ) GAAP EPS of -SEK0.27, revenue of SEK28.3M | 2 | Seeking Alpha | ||
| 18.02. | Senzime Secures Credit Line Facility of 50 MSEK | 249 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / February 18, 2026 / Senzime AB (publ.) (STO:SEZI)(OTCQX:SNZZF) announces that the company has secured a credit line facility of 50 MSEK. The credit facility has been... ► Artikel lesen | |
| 18.02. | Senzime Q4 2025: Accelerated Growth and Continued Clear Path to Profitability | 272 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / February 18, 2026 / Senzime AB's (publ.) (STO:SEZI)(OTCQX:SNZZF) year-end report for January - December 2025 is now available on the company's website www.senzime.com.Financial... ► Artikel lesen | |
| 11.02. | Invitation to Presentations of Senzime's Q4 and Year-End Report 2025 | 181 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / February 11, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime invites investors, analysts, and media to a webcast presentation of the fourth quarter and year-end report... ► Artikel lesen | |
| 21.01. | Senzime Secures Major Ivy League US Hospital System Contract | 255 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / January 21, 2026 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced that it has secured another strategic contract in the US with a leading Ivy League university hospital... ► Artikel lesen | |
| 21.01. | Senzime AB: Senzime secures major Ivy League US hospital system contract | 181 | GlobeNewswire (Europe) | Uppsala, Sweden, Jan 21, 2026 - Senzime AB today announced that it has secured another strategic contract in the US with a leading Ivy League university hospital system. The contract includes in its... ► Artikel lesen | |
| SENZIME Aktie jetzt für 0€ handeln | |||||
| 17.12.25 | Senzime's Next-Generation TetraGraph System Receives Regulatory Approval in Japan | 386 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / December 17, 2025 / Senzime AB (publ.) (STO:SEZI)(OTCQX:SNZZF) today announced that its Next-generation TetraGraph system has received regulatory clearance for sale in... ► Artikel lesen | |
| 10.12.25 | Senzime Unveils the Next Set of Innovations in Neuromuscular Monitoring With the Launch of EMGINE Sirius | 306 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / December 10, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ) today announced the launch of the latest series of innovative features for its next-generation... ► Artikel lesen | |
| 09.12.25 | Senzime Secures Major TetraGraph Order from Leading UK NHS Hospital System | 331 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / December 9, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ.) today announced that one of the leading NHS hospital trusts in the United Kingdom (UK) has ordered... ► Artikel lesen | |
| 11.11.25 | Senzime to Present at Redeye and BioStock Investor Conferences | 317 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / November 11, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF), a leader in solutions for personalized anesthesia, today announced that Philip Siberg, CEO of Senzime, will be presenting... ► Artikel lesen | |
| 03.11.25 | Nomination Committee for Senzime Annual General Meeting 2026 | 282 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESS Newswire / November 3, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - A Nomination Committee consisting of shareholder representatives has been established for Senzime AB (publ.)... ► Artikel lesen | |
| 29.10.25 | Senzime Q3 2025: Strong Growth and Clear Steps Towards Profitability | 305 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / October 29, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB's (publ) interim report for January - September 2025 is now available on the company's website www.senzime.com... ► Artikel lesen | |
| 23.10.25 | Invitation to Presentations of Senzime's Third Quarter 2025 Report | 283 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / October 23, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime invites investors, analysts, and media to a webcast presentation of the third quarter report for 2025 on... ► Artikel lesen | |
| 08.10.25 | Senzime Launches EMGINE, The Next-Generation Software Suite Advancing Neuromuscular Monitoring | 437 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / October 8, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ) today announced the launch of EMGINETM, a proprietary software suite for its next-generation TetraGraph®... ► Artikel lesen | |
| 03.10.25 | Senzime Welcomes New European Pediatric Guidelines Recommending EMG-Based Neuromuscular Monitoring | 351 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / October 3, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ) welcomes today's presentation at the ESPA congress in Berlin of the first-ever pediatric guidelines... ► Artikel lesen | |
| 17.09.25 | Senzime Awarded Contract to Supply the U.S. Department of Defense and Walter Reed National Military Medical Center | 336 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / September 17, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ) today announces that the U.S. Department of Defense has awarded a contract to supply the TetraGraph®... ► Artikel lesen | |
| 12.09.25 | Senzime to Present at Pareto Securities' 16th Annual Healthcare Conference | 370 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / September 12, 2025 / Senzime AB (Nasdaq Stockholm:SEZI)(OTCQX:SNZZF), a leader in precision-based monitoring during anesthesia, today announced that the company will... ► Artikel lesen | |
| 12.09.25 | Senzime Launches Integration with Mindray Patient Monitors | 391 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / September 12, 2025 / Senzime AB (publ) today announced the launch of new connectivity solutions to external data platforms, monitors, and electronic health records. The... ► Artikel lesen | |
| 09.09.25 | Senzime Welcomes New Japanese Guidelines on Neuromuscular Monitoring | 323 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / September 9, 2025 / Senzime AB (publ) (STO:SEZI)(OTCQX:SNZZF) - today announced that the Japanese Society of Anesthesiology (JSA) has published updated clinical guidelines... ► Artikel lesen |
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 23,620 | +0,08 % | Shortseller-Positionen aktuell: Carl Zeiss Meditec, Gerresheimer, GFT, Lanxess, Renk, Puma, TeamViewer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| ECKERT & ZIEGLER | 14,750 | -0,67 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| UNITEDHEALTH | 246,95 | +0,16 % | Dividendenbekanntmachungen (09.03.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADVANSIX INC US00773T1016 0,16 USD 0,1377 EUR ALLISON TRANSMISSION HOLDINGS INC US01973R1014 0,29 USD 0,2496 EUR ALPHABET INC CDR CA02080K1049 0... ► Artikel lesen | |
| GERRESHEIMER | 17,670 | -4,33 % | Aktien KW 11 Aktienmärkte hoffen auf TACO-Trade. Je länger der dauert, … News. Porsche. Nordex. 3U Holding. Grenke. Mutares. Gabler. Masterflex. Deutsche Beteiligungs AG. Deutsche Rohstoff. Nordex. Gerresheimer | Aktien: Eine weitere Woche Bomben auf den Iran, keine erkennbaren "Erfolge" - ausser das sinnlos Menschen sterben. Und langsam kommt der amerikanische Angriff bei der Welt an. Steigende Ölpreise an... ► Artikel lesen | |
| DRAEGERWERK | 86,50 | +1,76 % | DRAEGERWERK AG & CO KGAA ST zeigt strukturelle Schwäche | ||
| INTUITIVE SURGICAL | 413,95 | -0,01 % | Software-Boom nach KI-Krise?: Deshalb hat die Atlassian-Aktie jetzt 700% Potenzial! | ||
| THERMO FISHER | 407,45 | -0,11 % | Dividendenbekanntmachungen (13.03.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADIAN ASSET MANAGEMENT INC US10948W1036 0,1 USD 0,0868 EUR ALBEMARLE CORPORATION US0126531013 0,405 USD 0,3516 EUR ALEXANDRIA... ► Artikel lesen | |
| TELADOC HEALTH | 4,611 | -1,84 % | Teladoc Health Stock Pops - Here's Why | ||
| ESSILORLUXOTTICA | 206,40 | +0,29 % | EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 11, 2026 | ||
| ROKU | 81,16 | +1,00 % | Roku and X Games Expand U.S. Streaming Rights Partnership | ||
| HIMS & HERS HEALTH | 21,540 | +0,28 % | Novo Nordisk vor Deal - Hims & Hers mit Kurssprung | Der monatelange Konflikt zwischen Novo Nordisk und dem US-Telemedizinanbieter Hims & Hers könnte bald Geschichte sein. Laut einem Bericht der Nachrichtenagentur Bloomberg vom späten Freitagabend steht... ► Artikel lesen | |
| FAMICORD | 4,960 | -0,40 % | EQS-News: FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung | EQS-News: FamiCord AG
/ Schlagwort(e): 9-Monatszahlen
FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung... ► Artikel lesen | |
| M1 KLINIKEN | 14,860 | -2,88 % | M1 Kliniken schließt Verkauf von Haemato Pharm ab | Die M1 Kliniken AG hat den Verkauf der Haemato Pharm GmbH über ihre Mehrheitsbeteiligung Haemato AG an die Phoenix Group mit Wirkung zum Ablauf des 31. Januar 2026 abgeschlossen. Sämtliche Vollzugsbedingungen... ► Artikel lesen | |
| DEXCOM | 55,84 | -0,68 % | DexCom, Inc.: Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026 | New registry study data shows that long-term use of Dexcom G7 supports weight management and lowers A1C for people with Type 2 diabetes who aren't on insulin therapy1 reinforcing the need to... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 60,60 | 0,00 % | If You Invested $1000 In Boston Scientific Stock 15 Years Ago, You Would Have This Much Today |
Das Unternehmen SENZIME AB kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,422 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SENZIME AB finden Sie auf Wallstreet Online.